ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells

Molecular and Cellular Biochemistry

Volumn 379, Issue 1-2, 2013, Pages 161-169

  Cai, Duo Te ^a   Jin, Hua ^b   Xiong, Qi Xing ^a   Liu, Wei Guang ^a   Gao, Zhi Gang ^a   Gu, Gui Xiong ^b   Qiu, Yu Hui ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; ER stress and JNK signaling; Hepatoblastoma; Oridonin

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; INOSITOL; INOSITOL REQUIRING ENZYME 1; ORIDONIN; SALUBRINAL; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; THAPSIGARGIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DITERPENES, KAURANE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINTS; HEPATOBLASTOMA; HUMANS; MAP KINASE KINASE KINASE 5; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 8;

RABDOSIA RUBESCENS;

EID: 84878427065     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1638-2     Document Type: Article

References (29)

1. Ishak KG, Glunz PR (1967) Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 20:396-422
2. Haas JE, Muczynski KA, Krailo M, Ablin A, Land V, Vietti TJ, Hammond GD (1989) Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64:1082-1095
3. Lack EE, Neave C, Vawter GF (1982) Hepatoblastoma. A clinical and pathologic study of 54 cases. Am J Surg Pathol 6:693-705
4. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD (2000) Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18:2665-2675
5. Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J et al (1991) Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children's Cancer Study Group. J Clin Oncol 9:2167-2176
6. von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Burger D, Erttmann R, Harms D, Mildenberger H (1997) Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 33:1243-1249
7. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A (2002) Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94:1111-1120
8. Douglass EC, Green AA, Wrenn E, Champion J, Shipp M, Pratt CB (1985) Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 13:187-190
9. Czauderna P, Otte JB, Roebuck DJ, von Schweinitz D, Plaschkes J (2006) Surgical treatment of hepatoblastoma in children. Pediatr Radiol 36:187-191
10. Liu Z, Ouyang L, Peng H, Zhang WZ (2012) Oridonin: targeting programmed cell death pathways as an anti-tumour agent. Cell Prolif 45:499-507
11. Li CY, Wang EQ, Cheng Y, Bao JK (2011) Oridonin: an active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int J Biochem Cell Biol 43:701-704
12. Zhu Y, Xie L, Chen G, Wang H, Zhang R (2007) Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice. Pharmazie 62:439-444
13. Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004) Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome. J Asian Nat Prod Res 6:127-138
14. Zhang CL, Wu LJ, Tashiro S, Onodera S, Ikejima T (2004) Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway. Acta Pharmacol Sin 25:691-698
15. Ren KK, Wang HZ, Xie LP, Chen DW, Liu X, Sun J, Nie YC, Zhang RQ (2006) The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J Ethnopharmacol 103:176-180
16. Liu JJ, Huang RW, Lin DJ, Wu XY, Peng J, Pan XL, Song YQ, Lin Q, Hou M, Wang DN, Chen F, Zhang MH (2005) Oridonin-induced apoptosis in leukemia K562 cells and its mechanism. Neoplasma 52:225-230
17. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, Yuan J (2005) A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307:935-939
18. Zheng QY, Li PP, Jin FS, Yao C, Zhang GH, Zang T, Ai X (2012) Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells. Cell Signal 25:206-213
19. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287:664-666
20. Roduit R, Schorderet DF (2008) MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells. Apoptosis 13:343-353
21. Healy SJ, Gorman AM, Mousavi-Shafaei P, Gupta S, Samali A (2009) Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol 625:234-246
22. Wlodkowic D, Skommer J, McGuinness D, Hillier C, Darzynkiewicz Z (2009) ER-Golgi network-a future target for anti-cancer therapy. Leuk Res 33:1440-1447
23. Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13:89-102
24. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982-995
25. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ (2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 21:1249-1259
26. Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, Hughes PD, Michalak EM, McKimm-Breschkin J, Motoyama N, Gotoh T, Akira S, Bouillet P, Strasser A (2007) ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129:1337-1349
27. Yamaguchi H, Wang HG (2004) CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem 279:45495-45502
28. Wang H, Ye Y, Chu JH, Zhu GY, Fong WF, Yu ZL (2011) Proteomic and functional analyses reveal the potential involvement of endoplasmic reticulum stress and alpha-CP1 in the anticancer activities of oridonin in HepG2 cells. Integr Cancer Ther 10:160-167
29. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252